NCT01639612View on ClinicalTrials.gov

Pilot Study of Bone Marrow/Stem Cells in Grade IV Malignant Glioma

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

March 31, 2016

Study Completion Date

April 30, 2016

Conditions
Grade IV Malignant Glioma
Interventions
BIOLOGICAL

ALD-451

ALD-451 iv

Trial Locations (1)

27710

Duke University Medical Center, Durham

All Listed Sponsors
lead

Henry Friedman

OTHER

NCT01639612 - Pilot Study of Bone Marrow/Stem Cells in Grade IV Malignant Glioma | Biotech Hunter | Biotech Hunter